DBP International AB: transition of the SI053 clinical trials protocol to a new Clinical Trial Information System has been completed

  Double Bond Pharmaceutical International AB (publ) (“DBP” or “The Company”, org. No. 556991-6082) is pleased to announce the successful

READ MORE